Journal of Clinical Oncology
hideThe Journal of Clinical Oncology (JCO) is a medical journal published by the American Society of Clinical Oncology (ASCO). The Journal was founded in 1983 and publishes original research and review articles on topics relating to cancer. It is published 3 times a month. The Journal's impact factor in 2007 was 15.484, making it one of the highest-impact journals in the field of oncology.
For more information about Journal of Clinical Oncology, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with journal of clinical oncology
Insomnia prevalent among cancer patients who receive chemotherapy
Nov 23, 2009 |
not rated yet |
0
Three quarters of cancer patients and survivors treated with chemotherapy suffer insomnia or sleep disorders that often become chronic conditions, hindering patients' ability to fully recover, according to scientists at the ...
Early-stage, HER2-positive breast cancer patients at increased risk of recurrence
Nov 02, 2009 |
not rated yet |
0
Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, ...
Childhood cancer survivors experience suicidal thoughts decades after diagnosis
Oct 23, 2009 |
4 / 5 (1) |
0
Adult survivors of childhood cancer have an increased risk for suicidal thoughts, even decades after their cancer treatments ended, according to a study led by Dana-Farber Cancer Institute scientists.
Centralized Review Process Markedly Expedites Approval of Cancer Clinical Trials
Oct 19, 2009 |
not rated yet |
0
(PhysOrg.com) -- A Central Institutional Review Board (CIRB) for cancer clinical trials that was created by the National Cancer Institute (NCI), part of the National Institutes of Health, in 2001 helps trials start more quickly ...
Bias affects cell phone cancer risk findings
Oct 15, 2009 |
3.5 / 5 (10) |
5
(PhysOrg.com) -- A group of South Korean and American researchers has found studies of possible links between cell phones and brain tumors and other cancers vary in quality, and those suggesting there is little ...
African American lung cancer patients may have different response to new cancer-fighting drugs
Oct 07, 2009 |
not rated yet |
0
Clinical research out of University Hospitals Case Medical Center has found that African Americans with a common form of lung cancer have a lower frequency of drug-sensitizing genetic mutations, which may impact response ...
Novel breast tissue feature may predict woman's cancer risk
Oct 05, 2009 |
not rated yet |
0
Mayo Clinic researchers have found that certain structural features within breast tissue can indicate a woman's individual cancer risk. The findings appear online today in the Journal of Clinical Oncology.
New approach for the treatment of malignant brain tumors
Oct 01, 2009 |
4 / 5 (1) |
0
Initial chemotherapy alone after surgery is just as successful as initial radiation therapy for patients from whom a very malignant brain tumor (anaplastic glioma) was removed. With this treatment, the patients survive on ...
Blood test helps guide treatment and can impact quality of life for breast cancer patients
Sep 14, 2009 |
not rated yet |
0
With the goal of tailoring cancer interventions for the individual, researchers at the Lombardi Comprehensive Cancer Center at Georgetown have published the results of a prospective study that validates the use of a simple ...
Does the distance a patient has to travel affect where they choose to get their care?
Aug 31, 2009 |
not rated yet |
0
Do patients choose where to get their care based on how long it takes to them to get there? Researchers at Fox Chase Cancer Center have recently documented a growing trend in the centralization of cancer surgery—more patients ...
'Watchful waiting' is a viable option for prostate cancer patients with low-risk tumors
Aug 31, 2009 |
5 / 5 (2) |
1
Appropriately selected prostate cancer patients, including older men and men with small, low-risk tumors, may safely defer treatment for many years with no adverse consequences, according to a new study in the Journal of ...
Project Zero Delay accelerates drug's path to clinical trial
Aug 03, 2009 |
not rated yet |
0
A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six ...
Selenium intake may worsen prostate cancer in some, study reports
Jun 25, 2009 |
not rated yet |
0
BOSTON--Higher selenium levels in the blood may worsen prostate cancer in some men who already have the disease, according to a study by researchers at Dana-Farber Cancer Institute the University of California, San Francisco.
New study finds dramatic increase in metastatic colon cancer survival
May 26, 2009 |
not rated yet |
0
Novel chemotherapy and biological agents for metastatic colorectal cancer, combined with surgical advances in liver resection, have resulted in a dramatic increase in survival for patients with advanced disease, according ...
Green tea extract shows promise in leukemia trials
May 26, 2009 |
4.8 / 5 (4) |
0
Mayo Clinic researchers are reporting positive results in early leukemia clinical trials using the chemical epigallocatechin gallate (EGCG), an active ingredient in green tea. The trial determined that patients with chronic ...
